comparemela.com

Latest Breaking News On - Paul ehrlich medical institute - Page 1 : comparemela.com

Questions mount on AstraZeneca vaccine s ties to rare blood clots

What has been observed? The problems observed in some people vaccinated with AstraZeneca are not regular thromboses (formation of blood clots), as initially reported, but a “very atypical” phenomenon, the French Medicines Agency has said. It is about “thromboses of the large veins, atypical by their localization (cerebral in the majority, but also digestive) and usually associated with thrombocytopenia (a deficit in blood platelets) or with disorders of coagulation,” according to the ANSM. File: Britain’s Prime Minister Boris Johnson holds a vial of the AstraZeneca COVID-19 vaccine during a visit to a vaccination center at the Health and Well-being Centre in Orpington, south-east London, Monday, Feb. 15, 2021. (Jeremy Selwyn/Pool Photo via AP)

COVID-19: Why Have Some Countries Paused The AstraZeneca Jab?

Channels Television   Updated March 17, 2021 In this file photo taken on March 09, 2021 a medical worker holds a syringe and a vial of the British-Swedish AstraZeneca/Oxford vaccine during a vaccination campaign at the National Museum of Science and Technology Leonardo Da Vinci.  Miguel MEDINA / AFP   Why have several countries in Europe suspended use of the AstraZeneca vaccine, citing fears of blood clots, even as the European Union’s top regulator insists there is no evidence of a link and calls for the inoculations to continue? Germany, Italy, France and at several other nations say they need time to determine whether the vaccine is in any way responsible for very rare incidents of unusual blood events.

Why have some countries paused the AstraZeneca jab?

Why have some countries paused the AstraZeneca jab?
france24.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from france24.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.